Rennova Health, Inc. financial data

Industry
Services-General Medical & Surgical Hospitals, NEC
Location
400 S. Australian Avenue, Suite 800, West Palm Beach, FL
State of incorporation
DE
Fiscal year end
December 31
Former names
CollabRx, Inc. (to 10/28/2015), TEGAL CORP /DE/ (to 9/25/2012)
Latest financial report
10-K - Q4 2023 - Feb 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 14.1 % +29.7%
Quick Ratio 0.52 % -3.68%
Debt-to-equity -169 % -0.37%
Return On Equity 25.8 % +128%
Return On Assets -37.6 % -126%
Operating Margin 7.3 %

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 2.99M USD +608%
Common Stock, Value, Issued 4.06M USD +39.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 18.7M USD +43.8%
Revenue from Contract with Customer, Excluding Assessed Tax 18.7M USD +43.3%
General and Administrative Expense 9.44M USD +30.7%
Costs and Expenses 17.3M USD +19.8%
Operating Income (Loss) 1.37M USD -164%
Nonoperating Income (Expense) -1.68M USD -3.79%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -314K USD +89.7%
Income Tax Expense (Benefit) -185K USD
Net Income (Loss) Attributable to Parent -7.73M USD -135%
Earnings Per Share, Basic 0 USD/shares -100%
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 49K USD -90.2%
Accounts Receivable, after Allowance for Credit Loss, Current 3.09M USD -0.76%
Inventory, Net 198K USD -18.3%
Assets, Current 6.94M USD +9.14%
Property, Plant and Equipment, Net 4.32M USD +3.03%
Operating Lease, Right-of-Use Asset 359K USD -37.5%
Intangible Assets, Net (Excluding Goodwill) 259K USD 0%
Assets 20.3M USD -1.56%
Accounts Payable, Current 12.4M USD +10.4%
Employee-related Liabilities, Current 8.34M USD -1.12%
Accrued Liabilities, Current 15.4M USD -20.6%
Liabilities, Current 42.5M USD -13.8%
Operating Lease, Liability, Noncurrent 176K USD -51%
Liabilities 57.1M USD +15%
Retained Earnings (Accumulated Deficit) -1.71B USD -0.45%
Stockholders' Equity Attributable to Parent -36.8M USD -26.6%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -36.8M USD -26.6%
Liabilities and Equity 20.3M USD -1.56%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.14M USD
Net Cash Provided by (Used in) Financing Activities -855K USD -230%
Net Cash Provided by (Used in) Investing Activities -534K USD -320%
Common Stock, Shares Authorized 250B shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -248K USD +60%
Interest Paid, Excluding Capitalized Interest, Operating Activities 112K USD -85.3%
Deferred Tax Assets, Valuation Allowance 26.7M USD +12.4%
Deferred Tax Assets, Gross 27.5M USD +12.8%
Operating Lease, Liability 359K USD -37.5%
Payments to Acquire Property, Plant, and Equipment 220K USD
Lessee, Operating Lease, Liability, to be Paid 406K USD -40.4%
Property, Plant and Equipment, Gross 7.07M USD +0.49%
Operating Lease, Liability, Current 183K USD -14.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 46.8K USD -56.2%
Deferred Tax Assets, Operating Loss Carryforwards 17.7M USD +14.4%
Preferred Stock, Shares Authorized 5M shares 0%
Operating Lease, Payments 82.9K USD +47.5%
Additional Paid in Capital 1.67B USD -0.07%
Depreciation, Depletion and Amortization 311K USD -33.8%
Interest Expense 36.5K USD
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%